# Effect of Fenofibrate on Sleep Apnea Syndrome

> **NCT00816829** · PHASE2 · TERMINATED · sponsor: **Solvay Pharmaceuticals** · enrollment: 34 (actual)

## Conditions studied

- Dyslipidemia
- Sleep Apnea Syndrome
- Overweight
- Obesity

## Interventions

- **DRUG:** Placebo
- **DRUG:** Fenofibrate

## Key facts

- **NCT ID:** NCT00816829
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** The study was prematurely terminated because of slow recruitment
- **Last updated:** 2009-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816829, "Effect of Fenofibrate on Sleep Apnea Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00816829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*